Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii

Veterinary Parasitology

Volumn 177, Issue 3-4, 2011, Pages 281-289

  Hiszczyńska Sawicka, Elzbieta ^a   Oledzka, Gabriela ^b   Holec Gasior, Lucyna ^c   Li, Hong ^a   Xu, Janet Boyu ^a   Sedcole, Richard ^a   Kur, Józef ^c   Bickerstaffe, Roy ^a   Stankiewicz, Mirosław ^a  

^a LINCOLN UNIVERSITY   (New Zealand)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

DNA vaccine; GRA antigens; Toxoplasma gondii

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; PLASMID DNA; TOXOPLASMA GONDII DENSE GRANULE ANTIGEN 1 VACCINE; TOXOPLASMA GONDII DENSE GRANULE ANTIGEN 4 VACCINE; TOXOPLASMA GONDII DENSE GRANULE ANTIGEN 6 VACCINE; TOXOPLASMA GONDII DENSE GRANULE ANTIGEN 7 VACCINE; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; DRUG EFFICACY; IMMUNE RESPONSE; LIPOSOMAL GENE DELIVERY SYSTEM; NONHUMAN; SHEEP; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INTERFERON-GAMMA; LIPOSOMES; PLASMIDS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RANDOM ALLOCATION; SHEEP; SHEEP DISEASES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

OVIS ARIES; TOXOPLASMA GONDII;

EID: 79954584210     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2010.11.047     Document Type: Article

References (32)

1. Bivas-Benita M., Laloup M., Versteyhe S., Dewit J., De Braekeleer J., Jongert E., Borchard G. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int. J. Pharm 2003, 266:17-27.
2. Blanchard Ph., Mahé D., Cariolet R., Truong C., Le Dimna M., Arnauld C., Rose N., Eveno E., Albina E., Madec F., Jestin A. An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome. Vet. Microbiol. 2003, 94:183-194.
3. Cesbron M.F., Capron A. Excreted-secreted antigens of Toxoplasma gondii: their origin and role in the host parasite interaction. Res. Immunol. 1993, 144:41-44.
4. Cesbron-Delauw M.F. Dense granule organelles of Toxoplasma gondii: their role in the host parasite relationship. Parasitol. Today 1994, 10:293-296.
5. Desolme B., Mévélec M.N., Buzoni-Gatel D., Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 2000, 18:2512-2521.
6. Estes D.M., Closser N.M., Allen G.K. IFN-gamma stimulates IgG2 production from bovine B cells costimulated with anti-mu and mitogen. Cell Immunol. 1994, 154:287-295.
7. Estes D.M. Differentiation of B cells in the bovine. Role of cytokines in immunoglobulin isotype expression. Vet. Immunol. Immunopathol. 1996, 54:61-67.
8. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., Amendoeira R.R., Lannes-Vieira J. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 2003, 21:1327-1335.
9. Flegr J. Effects of toxoplasma on human behavior. Schizophr. Bull. 2007, 33:757-760.
10. Gilbert, R.E., See, S.E., Jones, L.V., Stanford, M.S., 2002. Antibiotics versus control for toxoplasma retinochoroiditis. Cochrane Database Syst. Rev. (1):CD002218.
11. Glasner P.D., Silveira C., Kruszon-Moran D., Martins M.C., Burnier J.M., Silveira S., Camargo M.E., Nussenblatt R.B., Kaslow R.A., Belfort R. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am. J. Ophthalmol. 1992, 114:136-144.
12. Golkar M., Shokrgozar M.A., Rafati S., Musset K., Assmar M., Sadaie R., Cesbron-Delauw M.F., Mercier C. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine 2007, 25:4301-4311.
13. Haumont M., Delhaye L., Garcia L., Jurado M., Mazzu P., Daminet V., Verlant V., Bollen A., Biemans R., Jacquet A. Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infect. Immun. 2000, 68:4948-4953.
14. Hiszczyńska-Sawicka E., Brillowska-Dabrowska A., Dabrowski S., Pietkiewicz H., Myjak P., Kur J. High yield expression and single step purification of Toxoplasma gondii SAG1, GRA1 and GRA7 antigens in Escherichia coli. Prot. Expr. Purif. 2003, 27:150-157.
15. Hiszczyńska-Sawicka E., Kur J., Pietkiewicz H., Holec L., Gasior A., Myjak P. Efficient production of the Toxoplasma gondii GRA6, p35 and SAG2 recombinant antigens and their applications in the serodiagnosis of toxoplasmosis. Acta Parasitologica 2005, 50:249-254.
16. Hiszczyńska-Sawicka E., Lee H., Xu J.B., Oledzka G., Kur J., Bickerstaffe R., Stankiewicz M. Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. Exp. Parasitol. 2010, 124:365-372.
17. Hughes H.P., van Knapen F. Characterisation of a secretory antigen from Toxoplasma gondii and its role in circulating antigen production. Int. J. Parasitol. 1982, 12:433-437.
18. Jongert E., de Craeye S., Dewit J., Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol. 2007, 29:445-453.
19. Jongert E., Melkebeek V., De Craeye S., Dewit J., Verhelst D., Cox E. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 2008, 26:1025-1031.
20. Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 1992, 15:211-222.
21. Martin V., Supanitsky A., Echeverria P.C., Litwin S., Tanos T., De Roodt A.R., Guarnera E.A., Sergio O., Angel S.O. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin. Diag. Lab. Immunol. 2004, 11:704-710.
22. Mercier C., Adjogble D.K.Z., Daubener W., Cesbron-Delauw M.F. Dense granules: are they key organelles to help understand the parasitophorous vacuole of all Apicomplexa parasites?. Int. J. Parasitol. 2005, 35:829-849.
23. Mévélec M.N., Bout D., Desolme B., Marchand H., Magné R., Bruneel O., Buzoni-Gatel D. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 2005, 23:4489-4499.
24. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect. Immun. 1999, 67:6358-6363.
25. Payne, R.W., 2009. The Guide to GenStat® Release 12. Part 2: Statistics Payne, R.W. et al. (Eds.), VSN International, UK.
26. Petersen E., Nielsen H.V., Christiansen L., Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 1998, 16:1283-1289.
27. Pietkiewicz H., Kur J., Hiszczyńska-Sawicka E., Petersen E., Nielsen H., Stankiewicz M., Myjak P. Usefulness of Toxoplasma gondii recombinant antigens in serodiagnosis of human toxoplasmosis. J. Clin. Microbiol. 2004, 42:1779-1781.
28. Pontarollo R.A., Rankin R., Babiuk L.A., Godson D.L., Griebel P.J., Hecker R., Krieg A.M., van Drunen Littel-van den Hurk S. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet. Immunol. Immunopathol. 2002, 84:43-59.
29. Scorza T., D'Souza S., Laloup M., Dewit J., De Braekeleer J., Verschueren H., Vercammen M., Huygen K., Jongert E. A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection. Infect. Immun. 2003, 71:309-316.
30. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., Saman E., Verschueren H. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect. Immun. 2000, 68:38-45.
31. Webster J.P., Lamberton P.H., Donnelly C.A., Torrey E.F. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc. Biol. Sci. 2006, 273:1023-1030.
32. Wood P.R., Jones S.L. BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis. Tuberculosis 2001, 81:147-155.